This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
NEJM.org
nejm.org
did:plc:mgwrki6irihfcatu2v347soc
NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains a trial investigating the efficacy and safety of psilocybin as a therapy for treatment-resistant depression.
Read the key results and comment from Peter Roy-Byrne, MD: jwat.ch/3Qc6EWH
#Psychiatry
2026-04-21T15:13:14.160Z